INmune Bio, Inc. (INMB)
1.78
+0.08
(+4.71%)
USD |
NASDAQ |
Dec 24, 12:59
1.82
+0.04
(+2.25%)
After-Hours: 13:59
INmune Bio Market Cap: 47.32M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 589.73M |
| Palatin Technologies, Inc. | 15.34M |
| Theriva Biologics, Inc. | 6.556M |
| Oragenics, Inc. | 0.6830M |
| NanoViricides, Inc. | 21.33M |
Market Cap Related Metrics
| PS Ratio | 842.48 |
| Price to Book Value | 1.865 |
| Price | 1.78 |
| Earnings Yield | -120.2% |